The 2022 FDA compounding restriction eliminated the previously available pathway through compounding pharmacies, narrowing the legal access routes further
Some researchers find the larger injection volumes less comfortable, especially for daily protocols, though retatrutide is administered weekly which makes this less of a concern
however, anytime you receive an injection theres a slight risk of allergic reaction
Research-supply guidance commonly calls for refrigerated storage at 2-8C after reconstitution, protected from light
12 mg subcutaneous daily , or 1 mg three times weekly , is the most commonly used GHK-Cu skin dose in published research and clinic practice
Consider timing : Maybe wait to start protocol until after trip